JAMES WILDER: Open Payments
NPI 1942298609 · TRION, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 98 payments from 15 companies in 2025. Trend: 2023 $1,281 · 2024 $1,372 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 60 | $607 |
| Boston Scientific Corporation | 5 | $290 |
| AstraZeneca Pharmaceuticals LP | 6 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $92 |
| Novo Nordisk Inc | 4 | $92 |
| PFIZER INC. | 4 | $82 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Exact Sciences Corporation | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $36 |
Products named: VRAYLAR, WATCHMAN FLX, UBRELVY, CDS - MCT/CEM Monitoring, CAPLYTA, Ozempic, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
